SG10201404903XA - Variant immunoglobulins with improved manufacturability - Google Patents
Variant immunoglobulins with improved manufacturabilityInfo
- Publication number
- SG10201404903XA SG10201404903XA SG10201404903XA SG10201404903XA SG10201404903XA SG 10201404903X A SG10201404903X A SG 10201404903XA SG 10201404903X A SG10201404903X A SG 10201404903XA SG 10201404903X A SG10201404903X A SG 10201404903XA SG 10201404903X A SG10201404903X A SG 10201404903XA
- Authority
- SG
- Singapore
- Prior art keywords
- improved manufacturability
- variant immunoglobulins
- immunoglobulins
- variant
- manufacturability
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/522—CH1 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0914691.1A GB0914691D0 (en) | 2009-08-21 | 2009-08-21 | Immunoglobulin variants |
| US24171709P | 2009-09-11 | 2009-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201404903XA true SG10201404903XA (en) | 2014-10-30 |
Family
ID=41171774
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201404903XA SG10201404903XA (en) | 2009-08-21 | 2010-08-20 | Variant immunoglobulins with improved manufacturability |
| SG2012009114A SG178340A1 (en) | 2009-08-21 | 2010-08-20 | Variant immunoglobulins with improved manufacturability |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012009114A SG178340A1 (en) | 2009-08-21 | 2010-08-20 | Variant immunoglobulins with improved manufacturability |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8951516B2 (zh) |
| EP (1) | EP2467400B1 (zh) |
| JP (1) | JP5901522B2 (zh) |
| KR (1) | KR20120056850A (zh) |
| CN (2) | CN106986935A (zh) |
| AU (1) | AU2010284841A1 (zh) |
| BR (1) | BR112012003571A2 (zh) |
| CA (1) | CA2771465A1 (zh) |
| DK (1) | DK2467400T3 (zh) |
| EA (1) | EA201290063A1 (zh) |
| GB (1) | GB0914691D0 (zh) |
| IL (1) | IL217993A0 (zh) |
| MX (1) | MX2012002100A (zh) |
| SG (2) | SG10201404903XA (zh) |
| TW (1) | TW201116626A (zh) |
| WO (1) | WO2011021009A1 (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2006381T3 (en) | 2006-03-31 | 2016-02-22 | Chugai Pharmaceutical Co Ltd | PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS |
| HUE029635T2 (en) | 2007-09-26 | 2017-03-28 | Chugai Pharmaceutical Co Ltd | A method for modifying an isoelectric point of an antibody by amino acid substitution in CDR |
| DK2708559T3 (en) | 2008-04-11 | 2018-06-14 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of repeatedly binding two or more antigen molecules |
| GB0914691D0 (en) | 2009-08-21 | 2009-09-30 | Lonza Biologics Plc | Immunoglobulin variants |
| TWI812066B (zh) | 2010-11-30 | 2023-08-11 | 日商中外製藥股份有限公司 | 具有鈣依存性的抗原結合能力之抗體 |
| JP6774164B2 (ja) | 2012-08-24 | 2020-10-21 | 中外製薬株式会社 | マウスＦｃγＲＩＩ特異的Ｆｃ抗体 |
| EP3721900A1 (en) | 2012-08-24 | 2020-10-14 | Chugai Seiyaku Kabushiki Kaisha | Fcgammariib-specific fc region variant |
| TWI636062B (zh) | 2013-04-02 | 2018-09-21 | 中外製藥股份有限公司 | Fc region variant |
| JP6829194B2 (ja) * | 2014-10-24 | 2021-02-10 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｖｈ−ｖｌドメイン間角度に基づく抗体ヒト化の方法 |
| TWI779010B (zh) | 2014-12-19 | 2022-10-01 | 日商中外製藥股份有限公司 | 抗肌抑素之抗體、含變異Ｆｃ區域之多胜肽及使用方法 |
| EP3253778A1 (en) | 2015-02-05 | 2017-12-13 | Chugai Seiyaku Kabushiki Kaisha | Antibodies comprising an ion concentration dependent antigen-binding domain, fc region variants, il-8-binding antibodies, and uses therof |
| US10953106B2 (en) | 2015-02-16 | 2021-03-23 | Lonza Ltd | Antibodies |
| EP3394098A4 (en) | 2015-12-25 | 2019-11-13 | Chugai Seiyaku Kabushiki Kaisha | ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE |
| CN109641960A (zh) | 2016-06-29 | 2019-04-16 | 检查点治疗公司 | Pd-l1特异性抗体及使用其的方法 |
| KR102538749B1 (ko) | 2016-08-05 | 2023-06-01 | 추가이 세이야쿠 가부시키가이샤 | Il-8 관련 질환의 치료용 또는 예방용 조성물 |
| SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
| CA3093729A1 (en) | 2018-03-15 | 2019-09-19 | Chugai Seiyaku Kabushiki Kaisha | Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of use |
| EP3772518A1 (en) * | 2019-08-07 | 2021-02-10 | Merus N.V. | Modified human variable domains |
| JP2024502832A (ja) * | 2020-12-31 | 2024-01-23 | アラマー バイオサイエンシーズ， インコーポレイテッド | 高親和性及び／または特異性を有する結合剤分子ならびにその製造及び使用方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5804187A (en) | 1992-11-16 | 1998-09-08 | Cancer Research Fund Of Contra Costa | Modified antibodies with human milk fat globule specificity |
| CA2150262C (en) | 1992-12-04 | 2008-07-08 | Kaspar-Philipp Holliger | Multivalent and multispecific binding proteins, their manufacture and use |
| KR101155191B1 (ko) * | 1999-01-15 | 2012-06-13 | 제넨테크, 인크. | 효과기 기능이 변화된 폴리펩티드 변이체 |
| US7700751B2 (en) * | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
| PE20020574A1 (es) * | 2000-12-06 | 2002-07-02 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido amiloideo beta |
| US20040110226A1 (en) * | 2002-03-01 | 2004-06-10 | Xencor | Antibody optimization |
| US7575893B2 (en) | 2003-01-23 | 2009-08-18 | Genentech, Inc. | Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
| WO2004101738A2 (en) | 2003-05-06 | 2004-11-25 | The Scripps Research Institute | Domain-exchanged binding molecules, methods of use and methods of production |
| ES2609102T3 (es) * | 2003-06-27 | 2017-04-18 | Bioren, LLC | Mutagénesis por revisión |
| BRPI0416141B8 (pt) * | 2003-11-01 | 2021-05-25 | Biovation Ltd | anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina |
| GB0325817D0 (en) * | 2003-11-05 | 2003-12-10 | Univ Cambridge Tech | Method and apparatus for assessing polypeptide aggregation |
| LT2348051T (lt) | 2003-11-05 | 2019-02-25 | Roche Glycart Ag | Cd20 antikūnai su padidintu fc receptoriaus prisijungimo giminingumu ir efektorine funkcija |
| US7276585B2 (en) * | 2004-03-24 | 2007-10-02 | Xencor, Inc. | Immunoglobulin variants outside the Fc region |
| DE602005026706D1 (de) | 2004-12-30 | 2011-04-14 | Us Government | Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung |
| US8029783B2 (en) | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| DOP2006000029A (es) | 2005-02-07 | 2006-08-15 | Genentech Inc | Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas) |
| NZ584769A (en) | 2007-09-28 | 2011-09-30 | Chugai Pharmaceutical Co Ltd | Anti-glypican-3 antibody having improved kinetics in plasma |
| CN102625813A (zh) | 2008-06-20 | 2012-08-01 | 诺华公司 | 具有降低的聚集的免疫球蛋白 |
| GB0914691D0 (en) | 2009-08-21 | 2009-09-30 | Lonza Biologics Plc | Immunoglobulin variants |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2009
- 2009-08-21 GB GBGB0914691.1A patent/GB0914691D0/en not_active Ceased
-
2010
- 2010-08-20 CN CN201611055580.XA patent/CN106986935A/zh active Pending
- 2010-08-20 WO PCT/GB2010/001579 patent/WO2011021009A1/en active Application Filing
- 2010-08-20 KR KR1020127007048A patent/KR20120056850A/ko not_active Application Discontinuation
- 2010-08-20 US US13/390,996 patent/US8951516B2/en active Active
- 2010-08-20 MX MX2012002100A patent/MX2012002100A/es not_active Application Discontinuation
- 2010-08-20 CN CN2010800408078A patent/CN102596994A/zh active Pending
- 2010-08-20 BR BR112012003571A patent/BR112012003571A2/pt not_active IP Right Cessation
- 2010-08-20 SG SG10201404903XA patent/SG10201404903XA/en unknown
- 2010-08-20 EA EA201290063A patent/EA201290063A1/ru unknown
- 2010-08-20 TW TW099128051A patent/TW201116626A/zh unknown
- 2010-08-20 DK DK10749484.1T patent/DK2467400T3/en active
- 2010-08-20 AU AU2010284841A patent/AU2010284841A1/en not_active Abandoned
- 2010-08-20 EP EP10749484.1A patent/EP2467400B1/en not_active Revoked
- 2010-08-20 CA CA2771465A patent/CA2771465A1/en not_active Abandoned
- 2010-08-20 SG SG2012009114A patent/SG178340A1/en unknown
- 2010-08-20 JP JP2012525202A patent/JP5901522B2/ja active Active
-
2012
- 2012-02-08 IL IL217993A patent/IL217993A0/en unknown
-
2015
- 2015-01-05 US US14/589,066 patent/US9290563B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2467400A1 (en) | 2012-06-27 |
| SG178340A1 (en) | 2012-03-29 |
| US20150104449A1 (en) | 2015-04-16 |
| GB0914691D0 (en) | 2009-09-30 |
| EA201290063A1 (ru) | 2012-12-28 |
| AU2010284841A1 (en) | 2012-03-15 |
| US8951516B2 (en) | 2015-02-10 |
| CN102596994A (zh) | 2012-07-18 |
| WO2011021009A1 (en) | 2011-02-24 |
| DK2467400T3 (en) | 2018-05-14 |
| CA2771465A1 (en) | 2011-02-24 |
| EP2467400B1 (en) | 2018-01-24 |
| TW201116626A (en) | 2011-05-16 |
| JP2013502402A (ja) | 2013-01-24 |
| BR112012003571A2 (pt) | 2016-11-22 |
| MX2012002100A (es) | 2012-06-19 |
| CN106986935A (zh) | 2017-07-28 |
| US9290563B2 (en) | 2016-03-22 |
| KR20120056850A (ko) | 2012-06-04 |
| JP5901522B2 (ja) | 2016-04-13 |
| IL217993A0 (en) | 2012-03-29 |
| US20120148568A1 (en) | 2012-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217993A0 (en) | Variant immunoglobulins with improved manufacturability | |
| ZA201202612B (en) | Combination | |
| EP2377932A4 (en) | ANTIBODIES AGAINST SIGLEC-15 | |
| EP2520815A4 (en) | LINEAR CAP | |
| GB0908027D0 (en) | Spetrophotometer with no moving parts | |
| IL219103A0 (en) | Combination | |
| IL219786A0 (en) | Combination | |
| ZA201202494B (en) | Combination | |
| ZA201202173B (en) | Combination | |
| EP2481868A4 (en) | ELEMENT FOR NOISE MITIGATION | |
| GB201011356D0 (en) | Ventalation arrangements | |
| ZA201202495B (en) | Combination | |
| ZA201202258B (en) | Combination | |
| IL218801A0 (en) | Combination | |
| GB0914172D0 (en) | Fixing | |
| GB0901800D0 (en) | Fixing element | |
| GB201206482D0 (en) | #magnotherapy | |
| GB0916277D0 (en) | Construction element | |
| PL118349U1 (pl) | Człon przesuwny | |
| GB201118431D0 (en) | No title# | |
| GB0916935D0 (en) | Fabricated crankshaft assemblies | |
| GB0921748D0 (en) | Switch-actuated arrangements | |
| GB0901391D0 (en) | Combination | |
| GB0906696D0 (en) | Combination | |
| UA21009S (uk) | Запальничка кремнієва |